Targeting AP-1 transcription factors by CRISPR in the prostate

Prostate cancer is the second most diagnosed cancer in men. It is a slow progressing cancer, but when the disease reaches an advanced stage, treatment options are limited. Sequencing analyses of cancer samples have identified genes that can potentially drive disease progression. We implemented the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Maria, Cai, Huiqiang, Stoltze, Iben C., Vendelbo, Mikkel H., Wagner, Erwin F., Bakiri, Latifa, Thomsen, Martin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448511/
https://www.ncbi.nlm.nih.gov/pubmed/34548912
http://dx.doi.org/10.18632/oncotarget.27997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448511/
https://www.ncbi.nlm.nih.gov/pubmed/34548912
http://dx.doi.org/10.18632/oncotarget.27997

Ejemplares similares